Cerebral amyloid angiopathy burden associated with leukoaraiosis: a positron emission tomography/magnetic resonance imaging study. - Wikidata - awgldk - TriplyDB

Cerebral amyloid angiopathy burden associated with leukoaraiosis: a positron emission tomography/magnetic resonance imaging study.

Cerebral amyloid angiopathy burden associated with leukoaraiosis: a positron emission tomography/magnetic resonance imaging study.

http://www.wikidata.org/entity/Q37025161

about

Amyloid PET in clinical practice: Its place in the multidimensional space of Alzheimer's disease Associations between white matter hyperintensities and β amyloid on integrity of projection, association, and limbic fiber tracts measured with diffusion tensor MRI Advances in understanding spontaneous intracerebral hemorrhage: insights from neuroimaging.White matter changes in dementia: role of impaired drainage of interstitial fluid.Cerebral amyloid angiopathy: emerging concepts Ischemic brain injury in cerebral amyloid angiopathy Diagnostic utility of amyloid PET in cerebral amyloid angiopathy-related symptomatic intracerebral hemorrhage.Inverse relationship between apolipoprotein A-I and cerebral white matter lesions: a cross-sectional study in middle-aged and elderly subjects.Amyloid positron emission tomography in sporadic cerebral amyloid angiopathy: A systematic critical update Outcome markers for clinical trials in cerebral amyloid angiopathy.Antemortem MRI findings associated with microinfarcts at autopsy.Interrelationship of superficial siderosis and microbleeds in cerebral amyloid angiopathy.The key role of transient receptor potential melastatin-2 channels in amyloid-β-induced neurovascular dysfunction.Structural network alterations and neurological dysfunction in cerebral amyloid angiopathy.Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly.Clinical and imaging features of mixed Alzheimer and vascular pathologies.Incidence of symptomatic hemorrhage in patients with lobar microbleeds.Dissociating Statistically-Determined Alzheimer's Disease/Vascular Dementia Neuropsychological Syndromes Using White and Gray Neuroradiological Parameters.White matter hyperintensity patterns in cerebral amyloid angiopathy and hypertensive arteriopathy.APOE ɛ2 is associated with white matter hyperintensity volume in CADASIL Cortical Superficial Siderosis in Memory Clinic Patients: Further Evidence for Underlying Cerebral Amyloid Angiopathy.Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association White matter hyperintensities are more highly associated with preclinical Alzheimer's disease than imaging and cognitive markers of neurodegeneration.Subjects harboring presenilin familial Alzheimer's disease mutations exhibit diverse white matter biochemistry alterations.Leukoaraiosis and increased cerebral susceptibility to ischemia: lack of confounding by carotid disease.Insight on AV-45 binding in white and grey matter from histogram analysis: a study on early Alzheimer's disease patients and healthy subjects.Cerebral microbleeds: a review of clinical, genetic, and neuroimaging associations.Cortical atrophy in patients with cerebral amyloid angiopathy: a case-control study.Cerebral microbleeds and macrobleeds: should they influence our recommendations for antithrombotic therapies?Cerebral amyloid angiopathy, subcortical white matter disease and dementia: literature review and study in OPTIMA.Prevalence of Brain Microbleeds in Alzheimer Disease: A Systematic Review and Meta-Analysis on the Influence of Neuroimaging Techniques.Familial Presenilin Mutations and Sporadic Alzheimer's Disease Pathology: Is the Assumption of Biochemical Equivalence Justified?Emerging concepts in sporadic cerebral amyloid angiopathy.Total Magnetic Resonance Imaging Burden of Small Vessel Disease in Cerebral Amyloid Angiopathy: An Imaging-Pathologic Study of Concept Validation White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer network.Intracranial Hemorrhage Risk in the Era of Antithrombotic Therapies for Ischemic Stroke.Small vessel disease burden in cerebral amyloid angiopathy without symptomatic hemorrhage.Imaging Vascular Disease and Amyloid in the Aging Brain: Implications for Treatment Amyloid PET imaging: applications beyond Alzheimer's disease.Florbetapir-PET to diagnose cerebral amyloid angiopathy: A prospective study.

P2860

Q27009411-CFAE9F74-DB30-46DC-BB8B-DE0BD81BFB84 Q28533723-C7897AAE-524C-4A9A-9DDB-BE8758A6ADCC Q30825729-54EBAE8F-8385-4883-B310-9C583CF4593F Q30880445-FF2BADB6-E4A7-45EC-AF49-AD1E538F9722 Q30894798-3086B98A-45F8-448F-9EF5-453783FEFADD Q30945201-D6ACB226-6B43-4B5A-A6F1-C76AE269ED91 Q33581237-FB81B4C0-0CD9-4D92-A0E2-04D415AF1CF8 Q33599314-13A3B2F1-5015-44F9-A557-C85222E16767 Q33700069-A223E27C-4014-4463-AE2C-B0743E8EFB89 Q33859442-88903FE8-4877-40D8-9A5A-13439365BF2C Q33927219-E917B24B-6FFC-4F2A-AB84-88A6A1B1BEBC Q34556470-84B9A4EE-E809-481A-9B0E-A424DC4AAC04 Q34820753-52C8501B-0D32-46B8-9371-564DA7B2DC11 Q34842317-1E7C6017-F9A0-4809-AC73-B77153BEA1DC Q35119419-74AC1975-54A9-48AD-AE2D-33553718A1C9 Q35125123-9ACE910D-EE00-4A6A-9352-0D87D1AE0A87 Q35142625-D113398C-C494-4356-8512-51ECC7B054BC Q36496101-E27F1BB6-5478-4AEB-AE81-164D983BBDCC Q36580370-865BD85E-4D2C-4241-8C05-7D52A5F63229 Q36593238-9A2F139C-796E-4904-BB1D-8E7F0A553797 Q36801636-D196D488-7842-43E8-8783-BE1D4BE0DBC3 Q37069527-A5C461FE-8202-4817-99B7-50F28F1863C9 Q37106748-592735CC-57E7-46A2-8EFF-87D6FBBB654D Q37199229-9634D6D9-51A5-4E83-BBEC-5E444870B941 Q37310404-3B8AB862-D0A5-4EC0-974A-135F6F2B54A0 Q37402288-5F195A34-11C1-4303-A7DC-FA94A1FBFF50 Q37435248-D3D2C4EB-427E-4723-94EB-EA0615A6B9CA Q37596048-6E69C347-8BEA-4522-B676-60A67535B538 Q37662448-2D1C5F9B-85DF-4BE7-9158-B4AE547185BB Q38292899-C158EBA2-7ECB-45BE-83AB-4BF8A72085C6 Q38658797-DA9C78B2-B1D0-47E0-89BC-EF64BF148D3B Q38693441-3C3C6809-2395-48B6-A2E5-90E82F0C904C Q39196370-968D4EE3-2101-46B3-AEDC-8342D71CF5DC Q39639734-DDCC0168-EC42-4431-A316-519717671339 Q39888008-0B05F001-759D-4DA9-A067-DF7EAEC2C528 Q39962487-BC1AA22A-542E-4D8E-9599-BB10254C3DDA Q40361221-799755F9-840A-456F-B9FE-CF9BA85D39B1 Q42653687-05709752-2BA4-494A-AE38-E7B12767B035 Q43161462-4F26584E-59E7-4B54-AA41-D56091881FD5 Q45425671-0E22E73B-6A9B-478B-A00D-8ED2494E4C0F

P2860

Cerebral amyloid angiopathy burden associated with leukoaraiosis: a positron emission tomography/magnetic resonance imaging study.

http://www.wikidata.org/entity/Q37025161

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 19 February 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Cerebral amyloid angiopathy bu ...... netic resonance imaging study.

@en

Cerebral amyloid angiopathy bu ...... netic resonance imaging study.

@nl

type

label

Cerebral amyloid angiopathy bu ...... netic resonance imaging study.

@en

Cerebral amyloid angiopathy bu ...... netic resonance imaging study.

@nl

prefLabel

Cerebral amyloid angiopathy bu ...... netic resonance imaging study.

@en

Cerebral amyloid angiopathy bu ...... netic resonance imaging study.

@nl

P1433

Q37025161-D090E497-D654-4149-9884-AD781E67F413

P1476

Q37025161-5A1E5420-B3C3-4B04-ABCA-52B268E56863

P2093

Q37025161-04DD3E2A-4220-4806-B457-7742B209E8EE

Q37025161-0BEE47BD-88F0-4B5D-B639-E67DDF3C35C6

Q37025161-20E7B049-771B-4249-9B20-6A628D926D21

Q37025161-21A6DDA2-5C69-4680-99D5-9809D928F64B

Q37025161-30E4AD7A-6BFB-462F-B074-D5710EF00735

Q37025161-3E862450-96F6-4DFA-B29F-E736FAF5DD9A

Q37025161-68BC3035-687B-4E49-9880-52862FF30118

Q37025161-797387DA-45AB-4284-93E0-78DCE136AE4A

Q37025161-869EAC64-9F69-4952-8C61-4D2A7275B616

Q37025161-95931614-4632-47C3-84F1-1D74BE63C0B0

P2860

Q37025161-073433C8-87A5-4127-8A5D-8F664491691D

Q37025161-0E30E5D1-7DD2-4353-98A7-238A110EFD9E

Q37025161-136FE6C1-1024-4141-8E3B-9CA1A729A9BD

Q37025161-13CC2086-80FA-4187-B8E1-AEBEC77BD026

Q37025161-16BE6194-F52C-4C69-98AF-90A788D205D5

Q37025161-1F694B7C-4662-4AD1-90D8-09E98E1DE471

Q37025161-2370190F-23EC-4E12-B6AD-C60AC918F25A

Q37025161-3298506B-BEE8-4B1F-9924-2498F0052267

Q37025161-360F54D1-5C8B-42E5-9F3C-4641A9FF49AC

Q37025161-404C5283-43F6-4968-B707-3D89F6B6BC25

P304

Q37025161-46176387-6BF3-4204-8042-9797314EB92C

P31

Q37025161-B859D0C8-050E-4D4F-ACF0-7586D8B8E3B0

P356

Q37025161-26A471C2-1514-4BB7-867D-DE19289E0493

P433

Q37025161-E7A777F1-6DC9-482C-89A1-39F37A95E13A

P478

Q37025161-8C4C2E0C-0451-414C-B5BC-D3C1A47592E0

P50

Q37025161-44CC24B1-3E70-409B-B7DA-43DA65CDD962

Q37025161-7707B080-6734-437D-AA59-BD860FE55498

P577

Q37025161-0A3596BA-DF92-4FEF-8F9C-B1F023651790

P698

Q37025161-CD4F9A74-2B33-4F7A-A61F-EC67BA0D2ED2

P932

Q37025161-35652055-AC37-46DC-A7FA-2DEAB52E2C67

P356

P1433

Annals of Neurology

P1476

Cerebral amyloid angiopathy bu ...... gnetic resonance imaging study

@en

P2093

Alex Becker

http://www.w3.org/2001/XMLSchema#string

Anand Viswanathan

http://www.w3.org/2001/XMLSchema#string

Anastasia Vashkevich

http://www.w3.org/2001/XMLSchema#string

Andrew Dumas

http://www.w3.org/2001/XMLSchema#string

Christopher Gidicsin

http://www.w3.org/2001/XMLSchema#string

Eitan Auriel

http://www.w3.org/2001/XMLSchema#string

Ellis van Etten

http://www.w3.org/2001/XMLSchema#string

Jeremy Carmasin

http://www.w3.org/2001/XMLSchema#string

Jonathan Rosand

http://www.w3.org/2001/XMLSchema#string

Keith A Johnson

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia?

A unified approach for morphometric and functional data analysis in young, old, and demented adults using automated atlas-based head size normalization: reliability and validation against manual measurement of total intracranial volume.

Cerebral microbleeds: a guide to detection and interpretation.

The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis

Spatial relation between microbleeds and amyloid deposits in amyloid angiopathy

Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.

Frontal lobe white matter hyperintensities and neurofibrillary pathology in the oldest old.

P304

529-536

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANA.23830

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

73

http://www.w3.org/2001/XMLSchema#string

P50

Mahmut Edip Gurol

P577

2013-02-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23424091

http://www.w3.org/2001/XMLSchema#string

P932

3715595

http://www.w3.org/2001/XMLSchema#string